Skip to main content

Table 2 Plasma somatostatin (SOM) and pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) levels determined by radioimmunoassay in healthy controls and Raynaud patients with or without symptoms. Data represent the means±SEM of each group

From: Impairment of microcirculation and vascular responsiveness in adolescents with primary Raynaud phenomenon

  Healthy Raynaud without symptoms Raynaud with symptoms
Somatostatin
(fmol/ml)
4.9 ± 0.3 4.9 ± 0.4 5.6 ± 0.5
PACAP-38
(fmol/ml)
15.8 ± 1.6 15.2 ± 1.5 13.1 ± 1.4